Boston Scientific Corporation and Guidant Corporation, In the Matter of

Last Updated:
In the Matter of Boston Scientific Corporation and Guidant Corporation
FTC Matter/File Number:

0610046

Enforcement Type:

Part 2 Consents

Case Summary

The consent order settles chargers that the $27 billion acquisition of Guidant Corporation by Boston Scientific Corporation would harm competition and consumers in several significant medical device markets. Guidant Corporation by Boston Scientific Corporation are the largest market shareholders in several coronary medical device markets in the U.S., together accounting for 90% of the U.S. PTCA balloon catheter market and 85% of the U.S. coronary guidewire market.